HPE vs PBYI · P/E 20, rev $32.19B vs P/E 4.3, rev $56.5M
Hewlett Packard Enterprise Co (HPE) versus Puma Biotechnology Inc (PBYI) — a side-by-side from cached financials, not a winner call.
Hewlett Packard Enterprise Co (HPE) is a communication equipment company listed on US.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Latest reported HPE revenue for 2026-07-31 was $32.19B. Net income was $2.62B. Revenue was up 61.1% from 2026-04-30 to 2026-07-31. HPE currently screens at market cap $27.19B and trailing P/E 19.9.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
HPE currently screens at market cap $27.19B and trailing P/E 19.9. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Not investment advice. Open the HPE and PBYI stock pages for the full models.
Not investment advice.